HS-10296
≥95%
- Product Code: 100856
CAS:
1899921-05-1
| Molecular Weight: | 562.11 g./mol | Molecular Formula: | C₃₀H₃₆ClN₇O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
HS-10296 is primarily used in the field of oncology as a targeted therapy for non-small cell lung cancer (NSCLC). It functions as an EGFR tyrosine kinase inhibitor, effectively blocking the signaling pathways that promote cancer cell growth and proliferation. This makes it particularly effective in treating patients with EGFR mutations, which are common in certain types of lung cancer. Clinically, it has shown promise in improving progression-free survival and overall response rates in patients who have developed resistance to first-generation EGFR inhibitors. Its application is often considered in advanced or metastatic cases where traditional treatments have failed. Additionally, ongoing research explores its potential in other cancers with EGFR-related mutations.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White Solid |
| Purity (%) | 94.5-100 |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿9,940.00 |
+
-
|
| 0.025 | 10-20 days | ฿31,990.00 |
+
-
|
| 0.100 | 10-20 days | ฿79,990.00 |
+
-
|
HS-10296
HS-10296 is primarily used in the field of oncology as a targeted therapy for non-small cell lung cancer (NSCLC). It functions as an EGFR tyrosine kinase inhibitor, effectively blocking the signaling pathways that promote cancer cell growth and proliferation. This makes it particularly effective in treating patients with EGFR mutations, which are common in certain types of lung cancer. Clinically, it has shown promise in improving progression-free survival and overall response rates in patients who have developed resistance to first-generation EGFR inhibitors. Its application is often considered in advanced or metastatic cases where traditional treatments have failed. Additionally, ongoing research explores its potential in other cancers with EGFR-related mutations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :